100 Influential People in Oncology 2026 – Nominations are Open!
FDA Approves OncoSil Device for Distal Cholangiocarcinoma
Geriatric Oncology in Brazil: Overcoming The Barriers to High-Quality Cancer Care For Older Adults
TP53-Mutated MDS: Can New Therapies Change the Prognosis?
CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab
Benny Johnson: Excited to Join Bristol Myers Squibb as Executive Director, Late-Stage Oncology for GI Cancers
TRUMPET Registry: mCRPC Treatment and Outcomes by Race, Initial Diagnosis, and Family History
Danny Burke: Study Identifying 272 Ongoing Cancer Clinical Trials in Brazil
The Advanced Course on the Management of HIPEC after CRS, organized by the European Society of Surgical Oncology (ESSO), will take place on February 3–5, 2027, in Berlin, Germany. This Level 1 advanced course focuses on cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and other intraperitoneal treatments for primary and secondary peritoneal malignancies. The multidisciplinary […]
